UK precision medicine centres announced

pharmafield logo - pharma news

The Precision Medicine Catapult, the UK’s innovation centre for precision medicine, has revealed that Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford will be the initial locations for its regional centres of excellence network.

Each centre will act as a hub for regional precision medicine activities within the UK-wide network, co-ordinated from the Cambridge headquarters. The Catapults are a UK Government initiative, established and part-funded through Innovate UK.

The centres will work on locally driven programmes and use the network “to harness the breadth of UK expertise, developing innovative technologies and solutions for broader use across the UK’s healthcare sector”. 

John McKinley, CEO of the Precision Medicine Catapult, said that project development work has been ongoing across the UK “and we will be launching offices and related programmes over the coming months.  As well as growing the UK’s strong position in precision medicine, we believe our network will deliver health and economic impact at a local and national level”.

Ruth McKernan, Innovate UK CEO, added that “understanding which types of patients will benefit most from treatments requires effective use of diagnostic testing and data-based insights. The Precision Medicine Catapult’s reach to patients for clinical trials purposes will be enhanced through the national network of centres of excellence”.